19 Oct Discover Brigham: Session Spotlight Series
Getting Ahead: Advances in Food and Drug Allergy
November 12, 2:25 – 2:55pm
Each year, more than 50 million Americans experience various types of allergies to plants, animals, food, or drugs (CDC, Gateway to Health Communication and Social Marketing Practice. Allergies.). The Brigham and Women’s Hospital Division of Allergy and Clinical Immunology is a national leader in food and drug allergy. We will review details of two new dedicated allergy clinics for evaluation of patients with food allergy and drug hypersensitivity. These specialized clinics not only work with patients and other health care providers, but also provide an opportunity for allergy related research. Two ongoing related research projects will be highlighted: 1) the Peanut Desensitization Clinic for young children [BH1] with peanut allergy which also explores the role of “baby” pre-mast cells and their contribution to food allergies and 2) the non-steroidal anti-inflammatory drug (NSAID) Challenge Clinic where we evaluate patients with a suspected ibuprofen, naproxen, or aspirin allergy in order to provide them with appropriate pain medications and avoid unnecessary overuse of opioids. Data gathered from patients in the NSAID Challenge Clinic show that ~80% of them no longer have an NSAID allergy and our research suggests risk factors for continued NSAID allergy.
Joyce Hsu, MD, Tanya Laidlaw, MD, Lily Li, MD, and Hannah Martin, MD
Register for Discover Brigham here!
Learn more about the other sessions and the rest of day on our website here!